Ranjeeta Thapa, George S. Wilson: The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer. In: Stem Cells International. Band2016, 2016, S.1–15, doi:10.1155/2016/2087204, PMID 27200096, PMC 4856920 (freier Volltext).
Hanxiao Xu et al.: The role of CD44 in epithelial–mesenchymal transition and cancer development. In: OncoTargets and Therapy. 2015, S.3783–3783, doi:10.2147/ott.s95470, PMID 26719706, PMC 4689260 (freier Volltext).
Sebastian Müller et al.: CD44 regulates epigenetic plasticity by mediating iron endocytosis. In: Nature Chemistry. Band12, Nr.10, 2020, S.929–938, doi:10.1038/s41557-020-0513-5, PMID 32747755.
Stéphanie Solier et al.: A druggable copper-signalling pathway that drives inflammation. In: Nature. Band617, Nr.7960, 2023, S.386–394, doi:10.1038/s41586-023-06017-4, PMID 37100912.
nih.gov
ncbi.nlm.nih.gov
Ranjeeta Thapa, George S. Wilson: The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer. In: Stem Cells International. Band2016, 2016, S.1–15, doi:10.1155/2016/2087204, PMID 27200096, PMC 4856920 (freier Volltext).
Hanxiao Xu et al.: The role of CD44 in epithelial–mesenchymal transition and cancer development. In: OncoTargets and Therapy. 2015, S.3783–3783, doi:10.2147/ott.s95470, PMID 26719706, PMC 4689260 (freier Volltext).
Sebastian Müller et al.: CD44 regulates epigenetic plasticity by mediating iron endocytosis. In: Nature Chemistry. Band12, Nr.10, 2020, S.929–938, doi:10.1038/s41557-020-0513-5, PMID 32747755.
Stéphanie Solier et al.: A druggable copper-signalling pathway that drives inflammation. In: Nature. Band617, Nr.7960, 2023, S.386–394, doi:10.1038/s41586-023-06017-4, PMID 37100912.